Amplitude Venture Capital logo

Amplitude Venture Capital

North America, Quebec, Canada, Montréal

Description

Amplitude Venture Capital is an investment firm.

Investor Profile

Amplitude Venture Capital has made 25 investments, with 6 in the past 12 months and 44% as lead.

Stage Focus

  • Series B (32%)
  • Series A (32%)
  • Seed (28%)
  • Series C (8%)

Country Focus

  • Canada (80%)
  • United States (16%)
  • Israel (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Genetics
  • Artificial Intelligence (Ai)
  • Oncology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Amplitude Venture Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 7
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 6
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 4
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 3
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Theodorus III
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Investissement Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 3
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does Amplitude Venture Capital often collaborate with?

Clarissa Desjardins
North America, Quebec, Canada, Montréal
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Amplitude Venture Capital?

Reverb Therapeutics

Vancouver, British Columbia, Canada

Reverb Therapeutics engages in the development of treatments for cancer and other diseases.

Health CareMedicalTherapeutics
SeedFeb 19, 2025
Amount Raised: $12,000,000
Fluid Biomed

Calgary, Alberta, Canada

Fluid Biomed is a clinical stage medical device company that develops polymer-based brain stent to cure aneurysms.

Health CareMedicalMedical Device
Series ADec 16, 2024
Amount Raised: $27,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Nomic

Montréal, Quebec, Canada

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

BiotechnologyHealth DiagnosticsMarket ResearchNanotechnology
Series BSep 17, 2024
Amount Raised: $42,000,000
Radiant Biotherapeutics

Toronto, Ontario, Canada

Radiant is a biotechnology company developing the next generation of multi-specificity.

BiotechnologyTherapeutics
Series ASep 11, 2024
Amount Raised: $35,000,000
Ability biologics

Ville-marie, Quebec, Canada

Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..

BiotechnologyLife Science
SeedJun 18, 2024
Amount Raised: $6,000,000
Ability biologics

Ville-marie, Quebec, Canada

Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..

BiotechnologyLife Science
SeedDec 6, 2023
Amount Raised: $12,000,000
Reverb Therapeutics

Vancouver, British Columbia, Canada

Reverb Therapeutics engages in the development of treatments for cancer and other diseases.

Health CareMedical
SeedNov 15, 2023
Tentarix Biotherapeutics

San Diego, California, United States

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

BiotechnologyLife ScienceMedical
Series BSep 6, 2023
Amount Raised: $35,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series BApr 26, 2023
Amount Raised: $50,000,000